Skip to main content

Table 3 Countries productive of schizophrenia trials ordered by level of productivity

From: Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study

country GDP (mUS $) actual trials > 100 predicted trials % predicted output (95% confidence intervals)
Finland 119834 38 2 1900 (1312–2488)
South Africa 129094 26 5 520 (340–700)
Denmark 161455 79 12 658 (525–792)
Canada 607702 275 118 233 (212–254)
Norway 153362 24 10 240 (167–313)
Greece 118172 15 2 750 (397–1103)
Switzerland 172400 54 15 360 (278–442)
Sweden 227757 101 28 361 (301–421)
Poland 135623 17 6 283 (175–392)
UK 1283335 669 279 240(226–254)
Netherlands 363342 104 60 173(152–196)
Belgium 242508 49 32 153 (128–178)
Austria 206236 33 23 143 (117–170)
USA 7824008 2363 1831 129 (127–132)
Hong Kong 175200 18 16 113 (95–130)
Australia 402787 64 70 91 (85–98)
India 388649 48 66 73 (60–85)
Germany 2089845 256 470 54 (48–61)
Nigeria 142920 4 8 50 (1–99)
China 901981 87 188 46 (36–57)
Turkey 191865 8 19 42 (8–76)
Thailand 153909 4 10 40 (-8–88)
Italy 1145370 91 246 37 (27–47
France 1394124 108 305 35 (26–44)
Spain 531289 32 100 32 (16–48)
Russian Federation 447103 21 80 26 (7–45)
Mexico 402109 13 69 19 (-2–40)
Iran 159391 2 12 17 (-35–68)
Saudi Arabia 134825 1 6 17 (-56–90)
Republic of Korea 442543 13 79 16 (-4–37)
Brazil 806972 21 166 13 (-2–27)
Argentina 323548 6 51 12 (-14–38)
Japan 4192669 113 969 12 (6–18)
Taiwan 308000 4 47 9 (-19–36)